Tango Therapeutics Inc. (TNGX), a clinical-stage biotechnology company, is scheduled to present at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting on November 7, 2025.
The company is focused on developing the next generation of precision medicine for cancer treatment. Its clinical pipeline includes oral PRMT5 inhibitors TNG462 and TNG456, as well as TNG260, an oral CoREST inhibitor.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.